Retinal Microvasculature as a Window into Systemic Health
Webinar replay with Dr. Céline Faure and Prof. Michel Paques
Can retinal microvascular assessment provide early and prognostic biomarkers for systemic diseases?
Recent advances in adaptive optics (AO) retinal imaging, and its combination with flicker stimulation, now enable quantitative, non-invasive assessment of microvascular structure and function, that conventional retinal imaging cannot capture. These capabilities open new avenues for clinical research in systemic disorders.
In this insightful webinar, Dr. Céline Faure and Prof. Michel Paques share:
- Novel microvascular biomarkers detectable through AO retinal imaging and functional assessment
- Clinical research applications across four systemic conditions: chronic kidney disease, hypertension, diabetes, and cognitive impairment
- Standardized protocols from studies conducted at 15-20 National Eye Hospital and Saint-Martin Private Hospital using rtx1 AO retinal cameras
- Unprecedented perspectives for your research projects
We are grateful to Dr. Céline Faure and Prof. Michel Paques for sharing their vision and clinical research experience with the rtx1 AO retinal camera.
About the panelists
Dr. Céline Faure, MD
Ophthalmologist, Saint Martin Hospital, Caen
Former Clinical Fellow, Fondation Ophtalmologique Adolphe de Rothschild
Dr. Faure specializes in medical and surgical retina. In the IRIR study conducted in collaboration with the Nephrology department, she investigated the prognostic value of microvascular metrics obtained with rtx1 AO camera in patients with end-stage chronic kidney disease.
Prof. Michel Paques, MD PhD
Professor of Ophthalmology, Quinze-Vingts National Eye Hospital
Researcher, Vision Institute
Prof. Paques pioneered the development of clinical applications of adaptive optics ophthalmoscopy for retinal and systemic diseases. As part of the SHIVA RHU program and MEDITWIN project, he is currently investigating retinal microvascular changes associated with neurodegenereation and cardiovascular risks.
Could microvascular assessments enhance your research ?
Which microvascular parameters are most relevant to your disease of interest? How could you implement such assessments in your clinical investigations or drug development programs? Learn more in the full replay and contact us with your questions.
